ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation

Xiang, Lei*; Cai, Xiangsheng; Zhao, Xiaoshan; Liu, Yuanling; Xiao, Ya; Jiang, Pingping; Yin, Lianghong*; Song, Dan*; Jiang, Xuefeng*广东药学院; 南方医科大学; 中国科学院研究生院; 1
Heliyon2023-11DOI: 10.1016/j.heliyon.2023.e21714
23阅读
引用收藏
分享

摘要

Background and aim: Diabetic Kidney Disease (DKD) is a common microvascular complication of diabetes mellitus. Multi-center, randomized controlled trials have shown that Qidan Dihuang Granule (QDDHG) reduces the levels of albuminuria of DKD. However, the specific mechanisms of QDDHG on DKD are not clarified. Thus, this study utilized network pharmacology, UHPLC-MS/ MS (Ultra-High Performance Liquid Chromatography - Mass Spectrometry) and animal experiments to reveal the mechanisms of QDDHG on DKD. Experimental procedure: Screening and retrieving active ingredients and corresponding targets of QDDHG on DKD through the TCMSP, ETCM, Disgenet, GeneCards, Omim and DrugBank databases. The PPI were performed with BioGrid, STRING, OmniPath, InWeb-IM. AutoDock Vina molecular docking module to estimate the validation from the compounds and target proteins. Free energy to estimate the binding affinity for identified compounds and target proteins. The ingredients of QDDHG were analyzed utilizing UHPLC-MS/MS. In vivo experiment with db/db mice were used to verify the targets and pathway predicted by network pharmacology. Results and conclusion: The results demonstrated that QDDHG has 18 active compounds and 13 target proteins of QDDHG exerted a crucial role in treatment of DKD. QDDHG affect the multiple biological processes included cellular response to lipid, response to oxidative stress, and various pathways, such as AGE-RAGE, PI3K-Akt, MAPK, TNF, EGFR, STAT3. The results of UHPLC-MS/ MS showed that six ingredients predicted by network pharmacology were also verified in experiment. In vivo experiment verified the effects of QDDHG on protecting the renal function mainly through inhibited the expression of EGFR, STAT3 and pERK in the db/db mice.

学科与关键词

关键词
Qidan Dihuang GranuleDiabetic kidney diseaseNetwork pharmacologyExperimental verificationTraditional Chinese medicine
相关
加载中…
  • Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease
    Chen, Yulian; Song, Xiaodan; Luo, Yunxia; Li, Guandong; Luo, Yueming; Wang, Ziyan; He, Riming; Lu, Jiandong; Xiong, Guoliang; Cheng, Hong*; Li, Huilin*; Yang, Shudong*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 9208017.
  • Deciphering the Pharmacological Mechanisms of Qidan Dihuang Decoction in Ameliorating Renal Fibrosis in Diabetic Nephropathy through Experimental Validation In Vitro and In Vivo
    Liang, Qiuer; Bai, Zhenyu; Xie, Ting; Lu, Hanqi; Xiang, Lei; Ma, Ke; Liu, Tianhao; Guo, Tingting; Chen, Liguo*; Zhao, Xiaoshan*; Xiao, Ya*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 4137578.被引 3
  • Combination of UHPLC-Q Exactive-Orbitrap MS, Bioinformatics and Molecular Docking to Reveal the Mechanism of Huan-Lian-Jie-Du Decoction in the Treatment of Diabetic Encephalopathy
    Cao, Dong-min; Liang, Qing-feng; Zhang, Zhi-tong; He, Wen-jiao; Tang, Dan*CHEMISTRY & BIODIVERSITY, 2023, 20(9).
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2023-11
卷期
第 9 卷, 第 11 期
页码
e21714
DOI
10.1016/j.heliyon.2023.e21714
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81804030]; Fellowship of China Post-doctoral Science Foundation [2022M711347, 2022M711536]; Natural Science Foundation of Guangdong Province, China [2018030310451, 2018A0303130320]; Traditional Chinese Medicine Bureau of Guangdong Province, China [20222203]; Major project of University of Chinese Academy of Science-Shenzhen Hospital , China [HRF-2021003]

作者

  • X

    Xiang, Lei (通讯) (第一作者)

    1 · univ chinese acad sci

  • C

    Cai, Xiangsheng

查看全部 9 位作者收起作者
  • Z

    Zhao, Xiaoshan

    southern med univ

  • L

    Liu, Yuanling

    guangdong women & children hosp

  • X

    Xiao, Ya

  • J

    Jiang, Pingping

    1 · guangdong pharmaceut univ

  • Y

    Yin, Lianghong (通讯)

    1

  • S

    Song, Dan (通讯)

    univ chinese acad sci

  • J

    Jiang, Xuefeng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417